by admin | Feb 10, 2016 | Archive
February 10, 2016 An FDA advisory panel on Tuesday voted to recommend approval of the sale of a biosimilar version of Johnson & Johnson’s arthritis drug infliximab (Remicade), which had U.S. sales of $4.45 billion last year. The copy was developed by... by admin | Feb 10, 2016 | Archive
February 10, 2016 FDA has approved fosaprepitant dimeglumine (Emend—Merck) to prevent delayed nausea and vomiting in adults receiving initial and repeat courses of moderately emetogenic chemotherapy (MEC). The drug is already approved for use in highly emetogenic... by admin | Feb 10, 2016 | Archive
February 10, 2016 The Pharmaceutical Research and Manufacturers of America (PhRMA) is unveiling a series of new advertisements to highlight the stories of its patients and researchers. Four new ads will hit digital, print, radio, and social media channels in 2016 as... by admin | Feb 10, 2016 | Archive
February 10, 2016 CVS Health’s fourth-quarter profit increased 13% due in large part to acquisitions, and company executives said Tuesday that they expect to reap more gains from their deal making later this year. CVS Health spent more than $10 billion to buy... by admin | Feb 10, 2016 | Archive
February 10, 2016 Patients with type 2 diabetes could benefit from evolocumab, a PCSK9 inhibitor that has been shown to reduce LDL cholesterol, according to a new study. Researchers analyzed three clinical trials made up of 413 patients with type 2 diabetes and 2,119... by admin | Feb 10, 2016 | Archive
February 10, 2016 Emergency department personnel often administer ketamine for procedural sedation of young patients, but analysis suggests that children older than 13 years are more likely to experience adverse respiratory and airway events with this anesthetic...